What Barson Corporation does

Barson Corporation is a private holding and business incubation company headquartered in Old Bethpage, New York, that forms, grows, and finances technically advanced businesses by taking majority or minority equity positions and providing strategic consulting plus corporate services (strategic management, initial financing, marketing, operational logistics, HR, and project management). The firm originated in high-performance surfaces and materials but has shifted toward biotechnology and software holdings, with current portfolio companies spanning three distinct technology domains.

Its operating subsidiaries include Himed LLC (calcium phosphate biomaterials, coatings, and surface treatments such as MATRIX® HA and MATRIX Dual® for orthopedic and dental implants, with an ISO 13485-certified and FDA-registered New York facility serving medical device manufacturers across six continents), Mercury Bio Inc. (a New Mexico-based biotech using engineered yeast extracellular vesicles, or yEV™, for targeted in-vivo delivery of proteins, nucleic acids, and small-molecule drugs), Big Giant Donut LLC (a software firm that acquired the 1983 Helix no-code database system in September 2022 and is reimagining it with Web3 functionality), and Frame Bio LLC (formed in 2024 to combine Himed and Mercury Bio capabilities for skin-bone axis therapies). Previous holdings include Hitemco, Hitemco Southwest, and Savsu Technologies.

Barson generates returns through equity appreciation in portfolio companies and through fees from strategic consulting and corporate services provided to those holdings. Revenue is not publicly disclosed; pricing is opaque and no funding rounds have been announced for the parent. CEO Dana Barnard leads the firm. Customer reach spans medical device OEMs (via Himed), pharmaceutical and biotech partners (via Mercury Bio), and SMBs/developers (via Big Giant Donut), with collaboration occurring across the portfolio as evidenced by the Himed-Mercury Bio research agreement that produced Frame Bio.

Name

Barson Corporation

Legal name

Barson Corporation

Website

https://barson.us

Company type

Private

Founded year

1974

Operating status

Operating

Headcount range

101–250 employees

Short description

Barson Corporation is a private New York-based holding company that forms, finances, and operates technically advanced businesses across biotechnology (Himed, Mercury Bio, Frame Bio) and no-code software (Big Giant Donut/Helix), serving medical device manufacturers, pharma partners, and SMB developers.

Ownership category

akta.pro rank

Product category

Private Equity Holding Company / Business Incubation

NAICS

Management of Companies and Enterprises (551)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

Keywords

• Business incubation services
• Private equity investment
• Bioceramics manufacturing
• Drug delivery platform
• No-code software

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Investment Returns and Portfolio Company Growth: Barson generates returns through equity positions (both majority and minority) in portfolio companies across biotechnology and software sectors. The company specializes in forming, growing, and financing highly unique, technically advanced businesses.
2. Strategic Consulting Services: Provides strategic consulting services including strategic management support, initial financing arrangements, marketing and branding, operational logistics, HR services, and project management to portfolio companies.
3. Corporate Services: Select corporate services provided to client-customers, including operational support and strategic guidance across various business functions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Core offering

Barson Corporation is a private holding and business incubator that forms, grows, and finances technically advanced businesses by taking majority and minority equity positions in portfolio companies. It provides strategic consulting and corporate services including strategic management support, initial financing, marketing and branding, operational logistics, HR, and project management. Its portfolio spans bioceramics manufacturing and surface treatments (Himed), yeast extracellular vesicle drug delivery (Mercury Bio), no-code software (Big Giant Donut), and skin-bone axis biotechnology (Frame Bio).

Product overview

Barson Corporation is a private investment company that specializes in forming, growing, and financing highly unique, technically advanced businesses. The company takes majority and minority positions in client-customers and provides strategic consulting and corporate services. The portfolio consists of four current investments: Himed LLC (bioceramics manufacturing and surface treatment), Mercury Bio Inc. (biotechnology and in-vivo drug delivery using yeast extracellular vesicles), Big Giant Donut LLC (no-code software for app building, including the Helix platform), and Frame Bio LLC (biotechnology focused on the skin-bone axis using Mercury Bio's platform). The company has evolved from its original focus on high-performance surfaces and materials into biotechnology and software spaces.

Differentiator

Problem solved

Functional benefit

Products and services

• Himed LLC Portfolio company manufacturing medical-grade hydroxyapatite (HA), custom calcium phosphate compounds, biocompatible abrasives, and MATRIX® surface treatment technologies for orthopedic, dental, and spinal implant manufacturers. Operates an ISO 13485-certified and FDA-registered facility in New York and delivers across six continents.
• Mercury Bio Inc. Portfolio company providing a proprietary yEV™ platform for targeted, cell-specific, in-vivo delivery of large- and small-molecule therapeutics including RNA, peptides, proteins, and small-molecule drug payloads. Offers collaborative development, biomaterials prototyping, and joint research partnerships from its New Mexico laboratory.
• Big Giant Donut LLC (Helix No-Code Platform) Portfolio company offering a reimagined no-code programming and database platform based on the legacy Helix system. Targets businesses, creatives, small teams, and software developers seeking intuitive tools for custom application development.
• Frame Bio LLC Portfolio company developing therapies targeting the skin-bone axis using Mercury Bio's yEV™ platform. Lead pipeline candidate is an mRNA therapy for collagen regeneration in wounds, skin, and hard-tissue damage.
• Strategic Consulting and Corporate Services Hands-on strategic management support, initial financing, marketing and branding, operational logistics, HR, and project management delivered to portfolio companies under Barson's incubation model.

Quantifiable outcome

• Delivery to nearly every organ group in the body demonstrated
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Himed-Mercury Bio Research CollaborationflagshipStrategic or Co-development Partner · 1 January 2024Strategic research collaboration between Himed (bioceramics) and Mercury Bio (drug delivery) that produced Frame Bio. This cross-company collaboration focuses on conditions affecting the skin-bone axis, leveraging shared cellular origins, collagen reliance, and common physiological pathways between skin and bones.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• ExoCoBio: Exosome-based biotech developing regenerative and therapeutic applications of extracellular vesicles — partially overlapping with Mercury Bio's yeast-EV delivery platform in the broader extracellular vesicle therapeutics space.
• Codiak BioSciences: Pioneering engineered exosome/vesicle platform company focused on precision drug delivery across multiple therapeutic areas — an early-to-mid-stage peer to Mercury Bio using a related (mammalian-cell-sourced) extracellular vesicle approach for targeted therapeutics.

Direct peers

• Bubble: Visual no-code platform for building web applications without coding — directly comparable to Big Giant Donut's positioning of Helix as a no-code tool empowering non-developers to build custom applications.
• Evox Therapeutics: UK-based biotech developing engineered extracellular vesicles for targeted delivery of nucleic acids, proteins, and small molecules — a directly comparable drug-delivery platform peer to Mercury Bio's yEV™ technology, addressing similar payload and targeting challenges.
• Patient Square Capital: Healthcare-focused private equity firm that takes majority and minority positions in biotech, medtech, and life-sciences companies and provides strategic operating support — directly comparable to Barson's model of forming, growing, and financing technically advanced healthcare businesses across multiple stages.
• Fortress Biotech: Biopharmaceutical holding company that acquires, develops, and commercializes multiple clinical-stage businesses across therapeutic areas — closely comparable to Barson's holding/incubator model of building and operating multiple distinct biotech assets.
• Cam Bioceramics: Specialty manufacturer of calcium phosphate biomaterials and coatings for orthopedic and dental implants — the closest specialty biomaterials peer to Himed, competing in the same medical-grade hydroxyapatite and surface-treatment categories.

Broad incumbents

• Airtable: Large-scale no-code platform enabling non-technical users to build database-driven applications — a broader incumbent to Big Giant Donut's Helix-based no-code approach, with significantly greater resources and ecosystem.
• DSM Biomedical (dsm-firmenich): Large diversified biomaterials and coatings supplier serving orthopedic, dental, and cardiovascular medical device markets — a broad incumbent against which Himed competes as a niche calcium phosphate specialist.
• Notion: Productivity and no-code workspace company with extensive templating and database capabilities — an incumbent competing in the same no-code/database category as Big Giant Donut's reimagined Helix platform.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barson Corporation